CIM
BSX icon

Contravisory Investment Management’s Boston Scientific BSX Stock Holding History

Contravisory Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,268
Closed -$598K – 377
2025
Q4 		$598K Sell
6,268
-242
-4% -$23.7K 0.12% 126
2025
Q3 		$636K Buy
6,510
+341
+6% +$35.3K 0.12% 123
2025
Q2 		$663K Sell
6,169
-82
-1% -$8.3K 0.13% 108
2025
Q1 		$631K Sell
6,251
-538
-8% -$54.2K 0.13% 106
2024
Q4 		$606K Sell
6,789
-684
-9% -$60.2K 0.13% 106
2024
Q3 		$626K Buy
7,473
+323
+5% +$25.5K 0.13% 105
2024
Q2 		$551K Sell
7,150
-295
-4% -$21.6K 0.12% 109
2024
Q1 		$510K Buy
7,445
+10
+0.1% +$643 0.11% 119
2023
Q4 		$430K Buy
7,435
+35
+0.5% +$1.87K 0.11% 142
2023
Q3 		$391K Sell
7,400
-390
-5% -$20.5K 0.11% 133
2023
Q2 		$421K Buy
+7,790
New +$407K 0.11% 133
2020
Q2 		– Sell
-1,989
Closed -$65K – 262
2020
Q1 		$65K Buy
1,989
+193
+11% +$7.54K 0.03% 203
2019
Q4 		$81K Buy
1,796
+262
+17% +$11K 0.03% 203
2019
Q3 		$62K Buy
+1,534
New +$65K 0.02% 213
2017
Q4 		– Sell
-22
Closed -$1K – 445
2017
Q3 		$1K Buy
+22
New +$608 ﹤0.01% 397
2015
Q1 		– Sell
-1,680
Closed -$22K – 167
2014
Q4 		$22K Sell
1,680
-815,552
-100% -$10.4M ﹤0.01% 102
2014
Q3 		$9.65M Sell
817,232
-50,476
-6% -$636K 2.01% 35
2014
Q2 		$11.1M Sell
867,708
-36,118
-4% -$470K 2.19% 31
2014
Q1 		$12.2M Buy
+903,826
New +$11.9M 2.4% 24

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Contravisory Investment Management's BSX Position: Q1 2026 in Review

Contravisory Investment Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,268 shares — an estimated $598K sold.

Contravisory Investment Management first reported a position in BSX in Q1 2014 and held it in 19 quarters. The position peaked at $12.2M in Q1 2014. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Contravisory Investment Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Contravisory Investment Management sold 6,268 Boston Scientific shares in Q1 2026, an estimated $598K.
  • Contravisory Investment Management first reported a position in Boston Scientific in Q1 2014 and held it in 19 quarters.
  • Contravisory Investment Management's Boston Scientific position peaked at $12.2M in Q1 2014.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.